Skip to main content
. 2015 Jan 29;8(1):1–16. doi: 10.1159/000373881

Table 1.

Subject characteristics and biochemical data

Control group (n = 11) Obese group (n = 12)
Male/female 7/4 12/0
Age, years 23 (18–27) 21.5 (19–28)
BMI, kg/m2 19.5 (18.1–21.7) 35.7 (32.0–44.9)***
BFM, kg 8.2 (6.0–14.9) 41.8 (26.6–63.0)***
PBF, % 14.6 (10.6–29.8) 39.1 (26.4–48.6)***
Visceral fat thickness, mm 23.2 (17.2–47.3) 69.4 (39.8–92.1)***
Subcutaneous fat thickness, mm 5.4 (3.2–9.9) 15.8 (11.5–29.8)***
Existence of fatty liver (+/–) 0/11 9/3
T-Bil, μmol/l 15.4 (5.1–34.2) 13.7 (6.8–35.9)
AST, U/l 17 (14–35) 25 (15–89)**
ALT, U/l 12 (9–42) 39.5 (13–189)***
γ-GTP, U/l 17 (11–28) 33.5 (14–133)**
ChE, U/l 276 (196–345) 406 (306–479)***
FBG, mmol/l 4.6 (4.3–5.1) 4.8 (4.2–5.3)
HbA1c, % 5.0 (4.7–5.9) 5.1 (4.5–5.6)
Insulin, μIU/ml 3.1 (2.2–6.4) 12.1 (6.3–32.4)***
HOMA-IR 0.7 (0.4–1.5) 2.6 (1.5–6.9)***
T-CHO, mmol/l 4.3 (3.7–5.5) 4.9 (3.6–10.5)
HDL-C, mmol/l 1.6 (1.3–2.5) 1.1 (0.8–1.3)***
LDL-C, mmol/l 2.2 (1.2–3.5) 3.4 (2.3–8.1)**
TG, mmol/l 0.5 (0.4–1.7) 1.2 (0.5–3.6)**
TP, g/l 73 (69–82) 73 (68–79)
Alb, g/l 47 (41–49) 44 (40–48)*
AMY, U/l 74 (59–229) 57.5 (36–75)**
BUN, mmol/l 4.2 (3.3–5.7) 3.8 (2.7–5.2)
Cre, μmol/l 71.6 (47.7–84.9) 67.6 (60.1–91.1)
UA, μmol/l 350.9 (148.7–452.0) 443.1 (232.0–535.3)**
CRP, mg/l 0.2 (0.0–4.8) 1.6 (0.2–28.1)**

BFM = Body fat mass; PBF = percent body fat; T-Bil = total bilirubin; AST = aspartate aminotransferase; ALT = alanine aminotransferase; γ-GTP = γ-glutamyl transpeptidase; ChE = cholinesterase; FBG = fasting blood glucose; HbA1c = hemoglobin A1c; HOMA-IR = homeostasis model assessment of insulin resistance; T-CHO = total cholesterol; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; TG = triglyceride; TP = total protein; Alb = albumin; AMY = amylase; BUN = blood urea nitrogen; Cre = creatinine; UA = uric acid; CRP = C-reactive protein.

*

p < 0.05

**

p < 0.01

***

p < 0.001 versus the control group.